Share This Page
Medibis Logo

Cannabinoid-based medicine for Australian patients

Personal Care & Healthcare

Australia

Offer

CSF

Series A

$670,929.90

raised by 602 investors

Min target

Minimum target hit!

CLOSED ON

28 March 2024

Overview

Leading the way with Medicinal Cannabis

Medibis is founded on a vision: making high quality, effective cannabinoid medicine accessible to patients. Our fully integrated business model is built with this ideal at its core, with patient outcomes guiding everything that we do.

We sit apart with our science-based approach. Medibis quality starts with the best genetics, strengthened by detailed analytics, and validated with clinical evidence.

We’re now bringing proven medicinal cannabis products to market, and launching our own trials, with a particular focus on treatments supporting mental health conditions and ASD. We’re deeply invested in our most important people - Australian patients.

Meet the team

Directors

Management

Product & Technology

Sales & Marketing

Advisors